However, when comparing the two main treatment options for HLAC, insulin infusion is increasingly preferred over plasmapheresis for managing severe hypertriglyceridemia, particularly in the context of hypertriglyceridemic pancreatitis [12]. This evidence concerns the gene INS and hypertriglyceridemia.